Birkenfeld, A.L. ; Bergman, M.* & Stefan, N.* Tirzepatide for obesity treatment and diabetes prevention. N. Engl. J. Med. 392, 2491-2492 (2025)
Garvey, W.T.* et al. Coadministered cagrilintide and semaglutide in adults with overweight or obesity. N. Engl. J. Med. 393, 635-647 (2025)
Global Cardiovascular Risk Consortium (Peters, A.) & Global Cardiovascular Risk Consortium (Thorand, B.) Global effect of cardiovascular risk factors on lifetime estimates. N. Engl. J. Med., DOI: 10.1056/NEJMoa2415879 (2025)
Krischer, J.P.* et al. SARS-CoV-2 - no increased islet autoimmunity or type 1 diabetes in teens. N. Engl. J. Med. 389, 474-475 (2023)
Magnussen, C.* et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl. J. Med. 389, 1273-1285 (2023)
Anker, S.D.* et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451-1461 (2021)
Pitt, B.* et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N. Engl. J. Med. 385, 2252-2263 (2021)
von Mutius, E. & Martinez, F.D.* Vitamin D supplementation during pregnancy and the prevention of childhood asthma. N. Engl. J. Med. 382, 574-575 (2020)
Husain, M.* et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 381, 841-851 (2019)
Körner, A.* ; Tschöp, M.H. & Blüher, M.* Five-year outcomes of gastric bypass in adolescents as compared with adults. N. Engl. J. Med. 381:e17 (2019)
Neumann, J.T.* et al. Application of high-sensitivity troponin in suspected myocardial infarction. N. Engl. J. Med. 380, 2529-2540 (2019)
Stitziel, N.O.* et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N. Engl. J. Med. 374, 1134-1144 (2016)
Stitziel, N.O.* et al. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (vol 374, pg 1134, 2016). N. Engl. J. Med. 374, 1898-1898 (2016)
Claussnitzer, M. et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895-907 (2015)
Nelson, C.P.* et al. Genetically determined height and coronary artery disease. N. Engl. J. Med. 372, 1608-1618 (2015)
Beuschlein, F.* et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019-1028 (2014)
TG and HDL Working Group (Crosby, J.R.* ; Peloso, G.M.* ; Auer, P.L.* ; Peters, A. ; Reiner, A.P.* ; Boerwinkle, E.* ; Kathiresan, S.*) Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014)
Liu, E. et al. Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42-49 (2014)
Navon Elkan, P.* et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N. Engl. J. Med. 370, 921-931 (2014)
Stand, E. Saxagliptin, alogliptin, and cardiovascular outcomes. N. Engl. J. Med. 370, 483-484 (2014)
Stitziel, N.O.* et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N. Engl. J. Med. 371, 2072-2082 (2014)
Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.) et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N. Engl. J. Med. 367, 1310-1320 (2012)
Ebert, M.P.* et al. TFAP2E-DKK4 and chemoresistance in colorectal cancer. N. Engl. J. Med. 366, 44-53 (2012)
Dolmans, G.H.* et al. Wnt signaling and Dupuytren's disease. N. Engl. J. Med. 365, 307-317 (2011)
Emerging Risk Factors Collaboration (Döring, A. ; Meisinger, C.) et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364, 829-841 (2011)
Eyerich, S. et al. Mutual antagonism of T cells causing psoriasis and atopic eczema. N. Engl. J. Med. 365, 231-238 (2011)
Moffatt, M.F.* et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363, 1211-1221 (2010)
Nalls, M.A.* et al. Failure to validate association between 12p13 variants and ischemic stroke. N. Engl. J. Med. 362, 1547-1550 (2010)
Samani, N.J.* et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007)
Peters, A. et al. Exposure to traffic and the onset of myocardial infarction. N. Engl. J. Med. 351, 1721-1730 (2004)
Plötz, S.G. et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N. Engl. J. Med. 349, 2334-2339 (2003)
Schmidt, J. et al. Evidence for an Osteoblast Activating Factor in a Patient With Peripherical T-Cell Lymphoma (PTCL) and Osteopetrosis. N. Engl. J. Med. (1988)